Stay Updated
Press Releases
WASHINGTON, D.C. —Today, the U.S. Court of Appeals for the Third Circuit rejected AstraZeneca’s challenge to the Medicare Drug Price Negotiation Program. The unanimous ruling marks the first appellate decision to evaluate and uphold the legality of the program’s core framework, dealing a major blow to pharmaceutical industry efforts to block lower drug prices. Patients For […]
Press Releases
ICYMI: David Mitchell Named One of Washington’s Most Influential People for Third Year in a Row
WASHINGTON, D.C. — Patients For Affordable Drugs’ founder and president, David Mitchell, has once again been included in Washingtonian’s Washington DC’s 500 Most Influential People of 2025. This marks the third consecutive year David has been recognized for his tireless work to lower prescription drug prices for patients across the country. “David’s relentless commitment to reforming the drug […]
Press Releases
To our Community, Today marks one hundred days into the new presidential administration. A key moment to take stock and reflect on where we are in the fight to lower drug prices for all Americans. Over the past several weeks, we’ve heard directly from nearly 1,000 people in our community – patients, family members, caregivers […]
Press Releases
Voters — including a majority of Trump supporters — demand action to lower drug prices as Big Pharma’s favorability plummets. WASHINGTON, D.C. — A new poll released last week, conducted by Trump pollster Fabrizio Ward and commissioned by Arnold Ventures, reveals just how potent the issue of prescription drug pricing has become, not just with voters overall, but with an overwhelming […]
Press Releases
WASHINGTON, D.C. — In response to President Trump’s new executive order on prescription drug prices, Merith Basey, Executive Director of Patients For Affordable Drugs, issued the following statement: “This executive order (EO) signals that the Administration recognizes the urgency of tackling high drug prices, in line with what the majority of Americans are demanding. The first round […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) has launched a new TV ad set to air nationally on Fox & Friends today. The ad encourages President Donald Trump to continue protecting Medicare’s ability to negotiate lower drug prices – a policy his Administration has defended in court and one that will save patients and taxpayers […]
Press Releases
RELEASE: All 12 Drug Manufacturers Agree To Participate In Second Round Of Medicare Negotiations
Patients For Affordable Drugs Welcomes Key Milestone While Holding Drug Companies Accountable For Ongoing Legal Attacks WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) announced Friday that all 12 manufacturers of the 15 drugs selected for the second round of the Medicare negotiation program voluntarily agreed to participate. While this is another critical step […]
Press Releases
WASHINGTON, D.C. — Today, Patients For Affordable Drugs (P4AD) filed an amicus brief in the U.S. Court of Appeals for the Third Circuit, defending Medicare’s ability to negotiate lower drug prices against a lawsuit brought by pharmaceutical giant Novartis. The lawsuit is part of a broader industry-wide legal assault aimed at dismantling the 2022 prescription drug law’s historic […]